156 related articles for article (PubMed ID: 9578086)
21. Androgen receptors frequently are expressed in breast carcinomas: potential relevance to new therapeutic strategies.
Moinfar F; Okcu M; Tsybrovskyy O; Regitnig P; Lax SF; Weybora W; Ratschek M; Tavassoli FA; Denk H
Cancer; 2003 Aug; 98(4):703-11. PubMed ID: 12910513
[TBL] [Abstract][Full Text] [Related]
22. [Immunohistochemical evaluation of estrogen and progesterone receptors on paraffin sections of breast carcinomas. Practical thoughts based on the study of 368 cases].
Balaton AJ; Baviera EE; Galet B; Vaury P; Vuong PN
Arch Anat Cytol Pathol; 1995; 43(1-2):93-100. PubMed ID: 7794034
[TBL] [Abstract][Full Text] [Related]
23. p16 expression in primary ovarian mucinous and endometrioid tumors and metastatic adenocarcinomas in the ovary: utility for identification of metastatic HPV-related endocervical adenocarcinomas.
Vang R; Gown AM; Farinola M; Barry TS; Wheeler DT; Yemelyanova A; Seidman JD; Judson K; Ronnett BM
Am J Surg Pathol; 2007 May; 31(5):653-63. PubMed ID: 17460447
[TBL] [Abstract][Full Text] [Related]
24. A comparison of estrogen receptor SP1 and 1D5 monoclonal antibodies in routine clinical use reveals similar staining results.
Brock JE; Hornick JL; Richardson AL; Dillon DA; Lester SC
Am J Clin Pathol; 2009 Sep; 132(3):396-401. PubMed ID: 19687316
[TBL] [Abstract][Full Text] [Related]
25. Ovarian metastases from colorectal carcinoma. Clinicopathologic profile, immunophenotype, and karyotype analysis.
Dionigi A; Facco C; Tibiletti MG; Bernasconi B; Riva C; Capella C
Am J Clin Pathol; 2000 Jul; 114(1):111-22. PubMed ID: 10884806
[TBL] [Abstract][Full Text] [Related]
26. Distinguishing breast carcinoma from Müllerian serous carcinoma with mammaglobin and mesothelin.
Kanner WA; Galgano MT; Stoler MH; Mills SE; Atkins KA
Int J Gynecol Pathol; 2008 Oct; 27(4):491-5. PubMed ID: 18753974
[TBL] [Abstract][Full Text] [Related]
27. Detection of estrogen receptor by immunohistochemistry in pulmonary adenocarcinoma.
Dabbs DJ; Landreneau RJ; Liu Y; Raab SS; Maley RH; Tung MY; Silverman JF
Ann Thorac Surg; 2002 Feb; 73(2):403-5; discussion 406. PubMed ID: 11845849
[TBL] [Abstract][Full Text] [Related]
28. A panel of immunohistochemical stains assists in the distinction between ovarian and renal clear cell carcinoma.
Cameron RI; Ashe P; O'Rourke DM; Foster H; McCluggage WG
Int J Gynecol Pathol; 2003 Jul; 22(3):272-6. PubMed ID: 12819395
[TBL] [Abstract][Full Text] [Related]
29. Neuroendocrine differentiation in carcinoma of the breast. Tyramide signal amplification discloses chromogranin A-positive tumour cells in more breast tumours than previously realized.
Bofin AM; Qvigstad G; Waldum C; Waldum HL
APMIS; 2002 Sep; 110(9):658-64. PubMed ID: 12529020
[TBL] [Abstract][Full Text] [Related]
30. Bone metastasis is strongly associated with estrogen receptor-positive/progesterone receptor-negative breast carcinomas.
Wei B; Wang J; Bourne P; Yang Q; Hicks D; Bu H; Tang P
Hum Pathol; 2008 Dec; 39(12):1809-15. PubMed ID: 18715613
[TBL] [Abstract][Full Text] [Related]
31. Hepatocyte paraffin 1 antibody does not distinguish primary ovarian tumors with hepatoid differentiation from metastatic hepatocellular carcinoma.
Pitman MB; Triratanachat S; Young RH; Oliva E
Int J Gynecol Pathol; 2004 Jan; 23(1):58-64. PubMed ID: 14668552
[TBL] [Abstract][Full Text] [Related]
32. Semi-automated imaging system to quantitate estrogen and progesterone receptor immunoreactivity in human breast cancer.
Sharangpani GM; Joshi AS; Porter K; Deshpande AS; Keyhani S; Naik GA; Gholap AS; Barsky SH
J Microsc; 2007 Jun; 226(Pt 3):244-55. PubMed ID: 17535263
[TBL] [Abstract][Full Text] [Related]
33. Apoptosis in breast carcinomas detected with monoclonal antibody to single-stranded DNA: relation to bcl-2 expression, hormone receptors, and lymph node metastases.
Frankfurt OS; Robb JA; Sugarbaker EV; Villa L
Clin Cancer Res; 1997 Mar; 3(3):465-71. PubMed ID: 9815706
[TBL] [Abstract][Full Text] [Related]
34. Estrogen and progesterone receptors in non small cell lung cancer patients.
Radzikowska E; Langfort R; Giedronowicz D
Ann Thorac Cardiovasc Surg; 2002 Apr; 8(2):69-73. PubMed ID: 12027790
[TBL] [Abstract][Full Text] [Related]
35. Determination of Her-2/Neu status in breast carcinoma: comparative analysis of immunohistochemistry and fluorescent in situ hybridization.
Jimenez RE; Wallis T; Tabasczka P; Visscher DW
Mod Pathol; 2000 Jan; 13(1):37-45. PubMed ID: 10658908
[TBL] [Abstract][Full Text] [Related]
36. Expression of oestrogen receptor and loss of E-cadherin are diagnostic for gastric metastasis of breast carcinoma.
van Velthuysen ML; Taal BG; van der Hoeven JJ; Peterse JL
Histopathology; 2005 Feb; 46(2):153-7. PubMed ID: 15693887
[TBL] [Abstract][Full Text] [Related]
37. Immunohistochemical panel of undifferentiated orbital metastatic carcinomas.
Godeiro KD; Odashiro AN; Odashiro DN; Fernandes BF; Burnier MN; Callejo S
Orbit; 2007 Jun; 26(2):101-6. PubMed ID: 17613856
[TBL] [Abstract][Full Text] [Related]
38. Expression of sialyl lewis X, sialyl Lewis A, E-cadherin and cathepsin-D in human breast cancer: immunohistochemical analysis in mammary carcinoma in situ, invasive carcinomas and their lymph node metastasis.
Jeschke U; Mylonas I; Shabani N; Kunert-Keil C; Schindlbeck C; Gerber B; Friese K
Anticancer Res; 2005; 25(3A):1615-22. PubMed ID: 16033070
[TBL] [Abstract][Full Text] [Related]
39. [Immunohistochemical diagnosis by means of tyramide signal amplification].
Qvigstad G; Falkmer S; Waldum HL
Tidsskr Nor Laegeforen; 2000 Jan; 120(2):236-8. PubMed ID: 10851922
[TBL] [Abstract][Full Text] [Related]
40. Estrogen receptor detection in paraffin sections of adenocarcinoma of the colon, pancreas, and lung.
Ollayos CW; Riordan GP; Rushin JM
Arch Pathol Lab Med; 1994 Jun; 118(6):630-2. PubMed ID: 8204009
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
